Edges in Network
| Network | GSE25065_top500tf - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | ATF2 |
| Upstream (Parents) |
|---|
| (<<) PLSCR1 → ATF2 |
| (<<) E2F3 → ATF2 |
| (<<) TBX10 → ATF2 |
| (<<) ATF6 → ATF2 |
| (<<) SOX9 → ATF2 |
| (<<) HSF1 → ATF2 |
| (<<) ZNF83 → ATF2 |
| (<<) ZNF217 → ATF2 |
| (<<) DMTF1 → ATF2 |
| (<<) STAT6 → ATF2 |
| (<<) E4F1 → ATF2 |
| Downstream (Children) |
|---|
| ATF2 → RUNX1T1 (>>) |
| ATF2 → SNAPC5 (>>) |
| ATF2 → POU2F3 (>>) |
| ATF2 → SCML1 (>>) |
| ATF2 → ZNF236 (>>) |
| ATF2 → BLZF1 (>>) |
| ATF2 → CREM (>>) |
| ATF2 → MYF5 (>>) |
| ATF2 → ZNF287 (>>) |
| ATF2 → FOSB (>>) |
| ATF2 → TFAP2C (>>) |
| ATF2 → SPI1 (>>) |
| ATF2 → CUX2 (>>) |
| ATF2 → TCF12 (>>) |
| ATF2 → SOX2 (>>) |
| ATF2 → PPARD (>>) |
| ATF2 → E2F8 (>>) |
| ATF2 → NR6A1 (>>) |
| ATF2 → ZNF154 (>>) |
| ATF2 → ARNTL (>>) |
| ATF2 → E2F6 (>>) |
| ATF2 → HOXA2 (>>) |
| ATF2 → MAFF (>>) |
| ATF2 → MYF6 (>>) |
| ATF2 → MSRB2 (>>) |
| ATF2 → TFDP2 (>>) |
| ATF2 → HOXA3 (>>) |
| ATF2 → ATF1 (>>) |
| ATF2 → NEUROG1 (>>) |
| ATF2 → HMG20B (>>) |
| ATF2 → ISL1 (>>) |
| ATF2 → NRL (>>) |
| ATF2 → TFCP2 (>>) |
| ATF2 → CEBPE (>>) |
| ATF2 → TCFL5 (>>) |
| ATF2 → SP140 (>>) |
| ATF2 → TAF5 (>>) |
| ATF2 → CEBPD (>>) |
| ATF2 → ETS1 (>>) |
| ATF2 → ZNF219 (>>) |
| ATF2 → RXRB (>>) |
| ATF2 → MYCL1 (>>) |
| ATF2 → ZNF24 (>>) |
| ATF2 → ZNF132 (>>) |
| ATF2 → ZNF140 (>>) |
| ATF2 → ZNF277 (>>) |
| ATF2 → HMGB2 (>>) |
| ATF2 → TBX4 (>>) |
| ATF2 → IRF2 (>>) |
